-MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis

Press/Media

Period	20 Sep 2023

Media coverage

Title	-MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
Media name/outlet	M2 PressWIRE
Country/Territory	United States
Date	20/09/23
URL	ct.moreover.com/?a=51853371883&p=1gw&v=1&x=jP0VAyeRc81vC1V6w_c3IQ
Persons	Bruce E. Sands